Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 1 |
GO:0031019 | mitochondrial mRNA editing complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0045293 | mRNA editing complex | 3 | 1 |
GO:0098798 | mitochondrial protein-containing complex | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: E9AU99
Term | Name | Level | Count |
---|---|---|---|
GO:0000959 | mitochondrial RNA metabolic process | 6 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0016556 | mRNA modification | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080156 | mitochondrial mRNA modification | 7 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1900864 | mitochondrial RNA modification | 6 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 65 | 69 | PF00656 | 0.601 |
CLV_NRD_NRD_1 | 158 | 160 | PF00675 | 0.595 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.626 |
CLV_PCSK_KEX2_1 | 158 | 160 | PF00082 | 0.588 |
CLV_PCSK_KEX2_1 | 166 | 168 | PF00082 | 0.544 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.657 |
CLV_PCSK_KEX2_1 | 57 | 59 | PF00082 | 0.663 |
CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.613 |
CLV_PCSK_PC1ET2_1 | 166 | 168 | PF00082 | 0.631 |
CLV_PCSK_PC1ET2_1 | 57 | 59 | PF00082 | 0.663 |
CLV_PCSK_PC1ET2_1 | 84 | 86 | PF00082 | 0.690 |
CLV_PCSK_SKI1_1 | 13 | 17 | PF00082 | 0.540 |
CLV_PCSK_SKI1_1 | 163 | 167 | PF00082 | 0.706 |
CLV_PCSK_SKI1_1 | 176 | 180 | PF00082 | 0.604 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.641 |
DOC_MAPK_gen_1 | 2 | 9 | PF00069 | 0.721 |
DOC_MAPK_gen_1 | 57 | 64 | PF00069 | 0.687 |
DOC_MAPK_MEF2A_6 | 2 | 11 | PF00069 | 0.714 |
DOC_PP4_FxxP_1 | 80 | 83 | PF00568 | 0.579 |
DOC_USP7_MATH_1 | 120 | 124 | PF00917 | 0.694 |
DOC_USP7_UBL2_3 | 57 | 61 | PF12436 | 0.682 |
DOC_WW_Pin1_4 | 101 | 106 | PF00397 | 0.696 |
DOC_WW_Pin1_4 | 115 | 120 | PF00397 | 0.591 |
DOC_WW_Pin1_4 | 13 | 18 | PF00397 | 0.598 |
LIG_14-3-3_CanoR_1 | 158 | 162 | PF00244 | 0.594 |
LIG_BIR_III_2 | 71 | 75 | PF00653 | 0.674 |
LIG_Clathr_ClatBox_1 | 8 | 12 | PF01394 | 0.596 |
LIG_FHA_2 | 108 | 114 | PF00498 | 0.733 |
LIG_NRBOX | 47 | 53 | PF00104 | 0.660 |
LIG_PCNA_yPIPBox_3 | 42 | 56 | PF02747 | 0.538 |
LIG_Pex14_1 | 76 | 80 | PF04695 | 0.586 |
LIG_PTAP_UEV_1 | 108 | 113 | PF05743 | 0.693 |
LIG_PTB_Apo_2 | 34 | 41 | PF02174 | 0.571 |
LIG_SH2_GRB2like | 35 | 38 | PF00017 | 0.570 |
LIG_SH2_STAP1 | 35 | 39 | PF00017 | 0.568 |
LIG_SH2_STAT5 | 149 | 152 | PF00017 | 0.520 |
LIG_SH2_STAT5 | 184 | 187 | PF00017 | 0.670 |
LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.577 |
LIG_SH3_3 | 106 | 112 | PF00018 | 0.666 |
LIG_SH3_3 | 87 | 93 | PF00018 | 0.749 |
LIG_TRAF2_1 | 93 | 96 | PF00917 | 0.616 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.728 |
MOD_DYRK1A_RPxSP_1 | 13 | 17 | PF00069 | 0.639 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.590 |
MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.699 |
MOD_GSK3_1 | 120 | 127 | PF00069 | 0.667 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.579 |
MOD_GSK3_1 | 176 | 183 | PF00069 | 0.550 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.563 |
MOD_NEK2_1 | 30 | 35 | PF00069 | 0.575 |
MOD_PKA_2 | 157 | 163 | PF00069 | 0.696 |
MOD_Plk_1 | 96 | 102 | PF00069 | 0.595 |
MOD_Plk_4 | 16 | 22 | PF00069 | 0.606 |
MOD_Plk_4 | 180 | 186 | PF00069 | 0.555 |
MOD_Plk_4 | 30 | 36 | PF00069 | 0.515 |
MOD_Plk_4 | 96 | 102 | PF00069 | 0.595 |
MOD_ProDKin_1 | 101 | 107 | PF00069 | 0.694 |
MOD_ProDKin_1 | 115 | 121 | PF00069 | 0.589 |
MOD_ProDKin_1 | 13 | 19 | PF00069 | 0.593 |
MOD_SUMO_rev_2 | 63 | 72 | PF00179 | 0.694 |
TRG_DiLeu_BaEn_1 | 170 | 175 | PF01217 | 0.677 |
TRG_DiLeu_BaEn_3 | 95 | 101 | PF01217 | 0.715 |
TRG_ENDOCYTIC_2 | 148 | 151 | PF00928 | 0.686 |
TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.581 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.654 |
TRG_ER_diArg_1 | 157 | 159 | PF00400 | 0.635 |
TRG_Pf-PMV_PEXEL_1 | 166 | 170 | PF00026 | 0.594 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDY3 | Leptomonas seymouri | 57% | 91% |
A0A0S4J9F6 | Bodo saltans | 31% | 72% |
A0A1X0NLX2 | Trypanosomatidae | 51% | 97% |
A0A3Q8IK45 | Leishmania donovani | 95% | 100% |
A0A422NK09 | Trypanosoma rangeli | 53% | 100% |
A4HQI6 | Leishmania braziliensis | 83% | 100% |
D0A3N4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 99% |
E9AHZ5 | Leishmania infantum | 95% | 100% |
Q4Q092 | Leishmania major | 94% | 100% |